Peg-interferon a-2a (40KD) with or without ribavirin in the treatment of naive patients with recurrent hepatitis C after liver transplantation

被引：0
|
作者：
Petrolati, A
Lionetti, R
Lenci, I
Di Paolo, D
Donato, F
Merli, M
Angeli, P
Burra, P
Strazzabosco, M
di Bergamo, O
Tisone, G
Angelico, M
机构：
[1] Univ Roma Tor Vergata, Hepatol Unit, Rome, Italy
[2] Univ Milan, Milan, Italy
[3] Univ Roma La Sapienza, Rome, Italy
[4] Univ Padua, Rome, Italy
[5] Osped Riuniti Bergamo, Rome, Italy
[6] Univ Roma Tor Vergata, Transplant Unit, Rome, Italy
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：482A / 482A
页数：1
相关论文
共 50 条
  • [31] Peginterferon alfa-2a (40KD) as prophylaxis and treatment for recurrent hepatitis C virus (HCV) infection after orthotopic liver transplantation (OLT)
    Chalasani, N
    Manzarbeitia, C
    Ferenci, P
    Vogel, W
    Fontana, R
    Voigt, M
    Riely, C
    Martin, P
    Teperman, LW
    Sidhu, R
    Jaio, J
    Lopez-Talavera, JC
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A664 - A664
  • [32] Interferon/ribavirin therapy for recurrent hepatitis C after liver transplantation.
    El-Amin, OA
    Poterucha, JJ
    Zein, NN
    Wiesner, RH
    Kim, WR
    Charlton, MR
    [J]. HEPATOLOGY, 1999, 30 (04) : 247A - 247A
  • [33] Comparison of ribavirin with PEG-interferon α-2a or with α-2b in treatment-naive patients
    Webb, Amy
    Poy, Isela
    Patel, Rikin
    Ali, Olga
    Page, Robert
    Kashi, Maryam
    Herrera, Ana
    Schoolfield, John
    Brock, Paul
    Hoyumpa, Anastacio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S181 - S182
  • [34] Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon α-2A and ribavirin:: A case report
    Taffaro, M.
    Pyrsopoulos, N.
    Cedron, H.
    Cacayorin, E.
    Weppler, D.
    Moon, J.
    Nishida, S.
    Levi, D.
    Kato, T.
    Selvaggi, G.
    Tzakis, A.
    Schiff, E.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) : 3435 - 3437
  • [35] Vitiligo Improvement in a Hepatitis C Patient After Treatment With PEG-Interferon α-2A and Ribavirin: A Case Report
    M. Taffaro
    N. Pyrsopoulos
    H. Cedron
    E. Cacayorin
    D. Weppler
    J. Moon
    S. Nishida
    D. Levi
    T. Kato
    G. Selvaggi
    A. Tzakis
    E. Schiff
    [J]. Digestive Diseases and Sciences, 2007, 52
  • [36] Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation
    Smallwood, GA
    Davis, L
    Connor, K
    Martinez, E
    Stieber, AC
    Heffron, TG
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1476 - 1477
  • [37] Pegylated interferon ALFA-2A and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, DV
    Weaver, L
    Schafer, DF
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S101 - S101
  • [38] PEG-Interferon alfa2b plus ribavirin treatment in chronic hepatitis C
    Müller, T
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (12) : 1192 - 1192
  • [39] Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) : 4403 - 4405
  • [40] Cyclosporine helps to achieve a higher SVR in patients receiving PEG-interferon/ribavirin for recurrent hepatitis C after liver transplantation: Final analysis of a randomized-controlled study
    Firpi, R. J.
    Soldevila-Pico, C.
    Morelli, G.
    Cabrera, R.
    Levy, C.
    Machicao, V. I.
    Michaels, A.
    Chen, C.
    Nelson, D. R.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S82 - S82
12345